Market Tracker

04/28 7:56am ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

96.26
Delayed Data
As of Apr 27
 +0.19 / +0.20%
Today’s Change
73.45
Today|||52-Week Range
102.49
+16.20%
Year-to-Date

Today’s Trading

Previous close96.07
Today’s open95.72
Day’s range95.01 - 98.95
Volume2,471,293
Average volume (3 months)1,118,634
Market cap$16.7B
Dividend yield--
Data as of 04/27/2017

Growth & Valuation

Earnings growth (last year)-256.07%
Earnings growth (this year)+74.73%
Earnings growth (next 5 years)+127.00%
Revenue growth (last year)+27.18%
P/E ratioNM
Price/Sales12.40
Price/Book6.01

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV+0.28+0.75%
PRGOPerrigo Company PLC+0.99+1.36%
SGENSeattle Genetics Inc+1.33+1.99%
JAZZJazz Pharmaceuticals...+4.26+2.70%
Data as of 04/27/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$1.1B
Annual profit (last year)-$630.2M
Net profit margin-56.74%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts